RELMADA THERAPEUTICS, INC. — Director's Dealing 2020

Dec 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2020-11-24

Reporting Person: CASAMENTO CHARLES J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-24	Common Stock	G	21223	$0.00	Disposed	27950	Direct
2020-12-01	Common Stock	S	3000	$35.7397	Disposed	24950	Direct

Footnotes

F1: Gift to a family trust.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $34.54 to $36.065. The average weighted price was $35.7397. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.